Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy

Abstract Aim Pancreatic ductal adenocarcinoma (PDAC) has the lowest survival rate of all major cancers. Chemotherapy is the mainstay systemic therapy for PDAC, and chemoresistance is a major clinical problem leading to therapeutic failure. This study aimed to identify key differences in gene express...

Full description

Bibliographic Details

Published in:	Cancer Medicine
Main Authors:	Sumit Sahni, Christopher Nahm, Mahsa S. Ahadi, Loretta Sioson, Sooin Byeon, Angela Chou, Sarah Maloney, Elizabeth Moon, Nick Pavlakis, Anthony J. Gill, Jaswinder Samra, Anubhav Mittal
Format:	Article
Language:	English
Published:	Wiley 2023-09-01
Subjects:	biomarkers chemotherapy response gene expression analysis neoadjuvant chemotherapy pancreatic ductal adenocarcinoma
Online Access:	https://doi.org/10.1002/cam4.6411